BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16868033)

  • 21. Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
    Lee SS; Jeong HE; Liu KH; Ryu JY; Moon T; Yoon CN; Oh SJ; Yun CH; Shin JG
    Pharmacogenet Genomics; 2005 Feb; 15(2):105-13. PubMed ID: 15861034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2J2 - regulation, function and polymorphism.
    Murray M
    Drug Metab Rev; 2016 Aug; 48(3):351-68. PubMed ID: 27286171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver.
    Hofmann MH; Blievernicht JK; Klein K; Saussele T; Schaeffeler E; Schwab M; Zanger UM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):284-92. PubMed ID: 18171905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
    Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
    Spiecker M; Liao J
    Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
    Schuetz JD; Kauma S; Guzelian PS
    J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
    Seubert J; Yang B; Bradbury JA; Graves J; Degraff LM; Gabel S; Gooch R; Foley J; Newman J; Mao L; Rockman HA; Hammock BD; Murphy E; Zeldin DC
    Circ Res; 2004 Sep; 95(5):506-14. PubMed ID: 15256482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension.
    Wu SN; Zhang Y; Gardner CO; Chen Q; Li Y; Wang GL; Gao PJ; Zhu DL
    Ann Hum Genet; 2007 Jul; 71(Pt 4):519-25. PubMed ID: 17286575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
    Zeldin DC; DuBois RN; Falck JR; Capdevila JH
    Arch Biochem Biophys; 1995 Sep; 322(1):76-86. PubMed ID: 7574697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
    Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
    Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus.
    Pucci L; Lucchesi D; Chirulli V; Penno G; Johansson I; Gervasi P; Del Prato S; Longo V
    Am J Pharmacogenomics; 2003; 3(5):355-8. PubMed ID: 14575523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes.
    Fava C; Montagnana M; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
    J Hypertens; 2010 Feb; 28(2):294-9. PubMed ID: 19851119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues.
    Trofimova-Griffin ME; Juchau MR
    Biochem Biophys Res Commun; 1998 Nov; 252(2):487-91. PubMed ID: 9826557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.
    Zeldin DC; Plitman JD; Kobayashi J; Miller RF; Snapper JR; Falck JR; Szarek JL; Philpot RM; Capdevila JH
    J Clin Invest; 1995 May; 95(5):2150-60. PubMed ID: 7738183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental transfer of the hypolipidemic drug, clofibrate, induces CYP4A expression in 18.5-day fetal rats.
    Simpson AE; Brammar WJ; Pratten MK; Cockcroft N; Elcombe CR
    Drug Metab Dispos; 1996 May; 24(5):547-54. PubMed ID: 8723735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
    Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dependent expression of cytochrome p450 epoxygenases during human prenatal development.
    Cizkova K; Konieczna A; Erdosova B; Ehrmann J
    Organogenesis; 2014 Jan; 10(1):53-61. PubMed ID: 24492490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.
    Arnold WR; Baylon JL; Tajkhorshid E; Das A
    Biochemistry; 2017 Dec; 56(51):6700-6712. PubMed ID: 29200270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of CYP2J2 polymorphism with susceptibility to psoriasis in Turkish population: a case-control study.
    Hayran Y; Allı N; Uysal Pİ; Çandar T
    An Bras Dermatol; 2020; 95(1):25-31. PubMed ID: 31902555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for the mutation-induced dysfunction of human CYP2J2: a computational study.
    Cong S; Ma XT; Li YX; Wang JF
    J Chem Inf Model; 2013 Jun; 53(6):1350-7. PubMed ID: 23647230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.